InflaRx NV (IFRX)
1.055
0.00 (0.00%)
USD |
NASDAQ |
Dec 10, 15:50
InflaRx EPS Diluted (Quarterly): -0.2115 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| CDT Equity, Inc. | -13.16 |
| LENZ Therapeutics, Inc. | -0.5851 |
| Liminatus Pharma, Inc. | -0.0675 |
| Oruka Therapeutics, Inc. | -0.6871 |
| Maze Therapeutics, Inc. | -0.6258 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -14.33M |
| Revenue (Quarterly) | 0.0278M |
| Total Expenses (Quarterly) | 14.36M |
| Enterprise Value | 20.49M |
| Gross Profit Margin (Quarterly) | -320.9% |
| Profit Margin (Quarterly) | -51.54K% |
| Earnings Yield | -86.88% |
| Normalized Earnings Yield | -84.20 |